Efficacy of the Therapeutic Vaccine TG4040 Combined With Pegylated Interferon and Ribavirin in Chronic HCV Patients

NCT01055821 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

140

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Hepatitis C Infection

Interventions

DRUG: pegylated interferon and ribavirin
BIOLOGICAL: TG4040 + SOC
BIOLOGICAL: TG4040 + SOC

Sponsor

Transgene